In Niger, mass distribution of antibiotics proves effective - study

2019-06-06 11:05
(iStock)

(iStock)

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

The mass administration of antibiotics to villages in Niger led to a reduction of a childhood mortality, without apparently creating resistance to antibiotics so feared by public health experts, according to a study.

But the study doesn't provide a final answer to this question, because other research has showed a more mixed impact of such distribution.

A team of researchers at the University of California San Francisco, UC Berkeley and the Carter Centre had a few years earlier carried out a first trial in Niger and some other African countries, called MORDOR 1, to confirm whether mass administration of the antibiotic azithromycin to children under five, twice a year, reduced overall mortality.

The antibiotic is effective against several bacteria, including E. coli and trachoma, a serious infectious disease that blinds around two million people a year, according to the World Health Organization.

The WHO runs a huge program which has distributed tens of millions of azithromycin doses to the worst affected countries.

In the MORDOR 1 trial, which was financed by the Bill and Melinda Gates Foundation, the researchers found that childhood mortality fell 18% across villages in Niger that received the treatment compared with those which did not or with children who received placebos.

Many questions

But the scientists still had a lot of questions: Would continuing to give out the medicines year after year see even more gains? Or, could it have the reverse effect of strengthening bacterial resistance?

For the next phase of the trial, MORDOR II, which began in its third year, all children under five in 594 communities received the antibiotic, in an oral suspension, twice in the year.

The results were clear, according to the paper published in the New England Journal of Medicine: Though the impact did not grow, there was no evidence of a waning effect.

Resistance was observed in laboratories but did not impact on-the-ground mortality rates.

And the results were almost immediate: Whether the villages received the antibiotic for the first time, or whether they were treated for the third consecutive year, mortality was reduced in similar proportions.

It remains to be seen whether resistance could develop in the longer term. The researchers will continue the experiment for another three years, says lead author Tom Lietman of the University of California San Francisco. "We'll find that out in about a year," he told AFP.

KEEP UPDATED on the latest news by subscribing to our FREE newsletter.

- FOLLOW News24 on Twitter

Read more on:    niger  |  west africa
NEXT ON NEWS24X

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.

Inside News24

 
Traffic Alerts
There are new stories on the homepage. Click here to see them.
 
English
Afrikaans
isiZulu

Hello 

Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.


Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Settings

Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.




Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.